Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer

被引:134
|
作者
Rodina, Anna
Vilenchik, Maria
Moulick, Kamalika
Aguirre, Julia
Kim, Joungnam
Chiang, Anne
Litz, Julie
Clement, Cristina C.
Kang, Yanlong
She, Yuhong
Wu, Nian
Felts, Sara
Wipf, Peter
Massague, Joan
Jiang, Xuejun
Brodsky, Jeffrey L.
Krystal, Geoffrey W.
Chiosis, Gabriela
机构
[1] Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Chem, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Program Canc Biol & Genet, New York, NY 10021 USA
[3] Virginia Commonwealth Univ, Med Coll Virginia, Dept Med, Richmond, VA 23249 USA
[4] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA
[5] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA
[6] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA
[7] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA
关键词
D O I
10.1038/nchembio.2007.10
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The heat shock protein 90 (Hsp90) has a critical role in malignant transformation. Whereas its ability to maintain the functional conformations of mutant and aberrant oncoproteins is established, a transformation-specific regulation of the antiapoptotic phenotype by Hsp90 is poorly understood. By using selective compounds, we have discovered that small-cell lung carcinoma is a distinctive cellular system in which apoptosis is mainly regulated by Hsp90. Unlike the well-characterized antiapoptotic chaperone Hsp70, Hsp90 is not a general inhibitor of apoptosis, but it assumes this role in systems such as small-cell lung carcinoma, in which apoptosis is uniquely dependent on and effected through the intrinsic pathway, without involvement of caspase elements upstream of mitochondria or alternate pathways that are not apoptosome-channeled. These results provide important evidence for a transformation-specific interplay between chaperones in regulating apoptosis in malignant cells.
引用
收藏
页码:498 / 507
页数:10
相关论文
共 50 条
  • [21] HSP-90 inhibitor ganetespib is synergistic with doxorubicin in small cell lung cancer
    Lai, C-H
    Park, K-S
    Lee, D-H
    Alberobello, A. T.
    Raffeld, M.
    Pierobon, M.
    Pin, E.
    Petricoin, E. F., III
    Wang, Y.
    Giaccone, G.
    ONCOGENE, 2014, 33 (40) : 4867 - 4876
  • [22] Identification of synergistic drug combinations with the oral HSP90 inhibitor Debio 0932 in non-small cell lung cancer and renal cell cancer
    Langdon, Casey G.
    Wiedemann, Norbert
    Hajjami, Helene Maby-El
    Held, Mathew A.
    Platt, James T.
    Vuagniaux, Gregoire
    Bosenberg, Marcus W.
    Stern, David F.
    Levy, Frederic
    CANCER RESEARCH, 2014, 74 (19)
  • [23] HSP-90 inhibitor ganetespib is synergistic with doxorubicin in small cell lung cancer
    C-H Lai
    K-S Park
    D-H Lee
    A T Alberobello
    M Raffeld
    M Pierobon
    E Pin
    E F Petricoin III
    Y Wang
    G Giaccone
    Oncogene, 2014, 33 : 4867 - 4876
  • [24] Hsp90 inhibitor induces autophagy and apoptosis in osteosarcoma cells
    Mori, Masaki
    Hitora, Toshiaki
    Nakamura, Osamu
    Yamagami, Yoshiki
    Horie, Ryosuke
    Nishimura, Hideki
    Yamamoto, Tetsuji
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 46 (01) : 47 - 54
  • [25] The role of Hsp90 in regulation of apoptosis in pancreatic cancer
    Mason, AB
    Burkitt, M
    Magee, CJ
    O'Connor, D
    Greenhalf, W
    BRITISH JOURNAL OF CANCER, 2001, 85 : 54 - 54
  • [26] HSP90 inhibition leads to a differential proteomics profile in non small cell lung cancer cell lines
    Marrugal, Angela
    Ferrer, Irene
    Pastor, Maria Dolores
    Quintanal, Alvaro
    Lucena-Cacace, Antonio
    Carnero, Amancio
    Paz-Ares, Luis
    Molina-Pinelo, Sonia
    CANCER RESEARCH, 2017, 77
  • [27] Organ-specific efficacy of HSP90 inhibitor in multiple-organ metastasis model of chemorefractory small cell lung cancer
    Takeuchi, Shinji
    Fukuda, Koji
    Arai, Sachiko
    Nanjo, Shigeki
    Kita, Kenji
    Yamada, Tadaaki
    Hara, Eiji
    Nishihara, Hiroshi
    Uehara, Hisanori
    Yano, Seiji
    INTERNATIONAL JOURNAL OF CANCER, 2016, 138 (05) : 1281 - 1289
  • [28] Anticancer activity of Hsp90 inhibitor AUY922 in nasopharyngeal carcinoma and non-small cell lung cancer cells
    Cho, William C.
    Wong, Chi F.
    CANCER RESEARCH, 2023, 83 (07)
  • [29] Cleavage of HSP90β induced by histone deacetylase inhibitor and proteasome inhibitor modulates cell growth and apoptosis
    Sangkyu Park
    Jae-Hyung Jeon
    Jeong-A Park
    Jun-Kyu Choi
    Younghee Lee
    Cell Stress and Chaperones, 2021, 26 : 129 - 139
  • [30] Hsp90 inhibitor gedunin causes apoptosis in A549 lung cancer cells by disrupting Hsp90:Beclin-1:Bcl-2 interaction and downregulating autophagy
    Hasan, Adria
    Haque, Ejazul
    Hameed, Rohil
    Maier, Paul N.
    Irfan, Safia
    Kamil, Mohd
    Nazir, Aamir
    Mir, Snober S.
    LIFE SCIENCES, 2020, 256